Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer – Results of a phase 1b clinical trial
Open Access
- 15 February 2024
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 201, 113926
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim Pharma GmbH und Co. KG
This publication has 14 references indexed in Scilit:
- Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the ‘burden of therapy’ methodEuropean Journal of Cancer, 2021
- Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center studyBMC Cancer, 2020
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic CancerNew England Journal of Medicine, 2018
- Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the ‘Arbeitsgemeinschaft Internistische Onkologie’European Journal of Cancer, 2018
- Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS StatusTargeted Oncology, 2015
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine, 2013
- EGF Receptor Is Required for KRAS-Induced Pancreatic TumorigenesisCancer Cell, 2012
- EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cellsBritish Journal of Cancer, 2011
- Dose Escalation Methods in Phase I Cancer Clinical TrialsJNCI: Journal of the National Cancer Institute, 2009